Add like
Add dislike
Add to saved papers

Osteoblastoma: clinicopathologic study of 306 cases.

Human Pathology 1994 Februrary
The clinical, radiologic, and pathologic features of 306 osteoblastomas were analyzed. Seventy-five were Mayo Clinic cases and 231 were from consultation files. Males outnumbered females two to one. The age range was 6 months to 75 years (mean age, 20.4 years). The vertebral column including the sacrum was the most frequent site (32%). Pain was the usual complaint and neurologic findings were associated with vertebral tumors. Although most tumors were well circumscribed, cortical expansion and destruction were common radiographic findings (39%), and 12% had features suggestive of malignancy. Large, epithelioid osteoblasts were seen in 24% and were the predominant cellular element in 10%. A distinctive epithelioid multifocal pattern was recognized. Recurrence rates were 16% (Mayo Clinic cases) and 21% (consultation cases). Tumors involving the central neuraxis were associated with greater morbidity and mortality. Aggressive behavior is within the biologic spectrum of osteoblastomas, and histopathology alone does not appear to be a reliable predictor of aggressiveness. The most important differential diagnosis is osteosarcoma.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app